pentetic acid has been researched along with lysine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritz, B; Hnatowich, DJ; Rusckowski, M | 1 |
| Baynes, JW; Blackledge, JA; Fu, MX; Lyons, TJ; Thorpe, SR; Wells-Knecht, KJ | 1 |
| Bakker, WH; Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Rolleman, EJ; Visser, TJ | 1 |
| Alvarez-Diez, TM; Polihronis, J; Reilly, RM | 1 |
| Duncan, JR; Edwards, WB; Franano, FN; Welch, MJ | 1 |
| Bakker, WH; Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Mäcke, H; Rolleman, EJ; Visser, TJ | 1 |
| Horiuchi, S; Itabe, H; Jono, T; Myint, T; Nagai, R; Sakata, N; Takano, T; Takebayashi, S; Takeya, M; Taniguchi, N; Uesugi, N | 1 |
| de Jong, M; Kooij, PP; Krenning, EP; Rolleman, EJ; Valkema, R | 1 |
| Al-Jamri, L; Davies, JS | 1 |
| Boerman, OC; Corstens, FH; Goldenberg, DM; Griffiths, GL; McBride, WJ; Oosterwijk, E; Oyen, WJ; Soede, AC; van Schaijk, FG | 1 |
| Bishop, TC; Blake, DA; Delehanty, JB; Jones, RM | 1 |
| Chung, JK; Hong, MK; Jeong, JM; Kang, JH; Kim, YJ; Lee, DS; Lee, J; Lee, MC | 1 |
| Berndorff, D; Borkowski, S; Cyr, JE; Dinkelborg, LM; Friebe, M; Hilger, CS; Rother, A; Sieger, S; Viti, F | 1 |
| de Jong, M; Huijmans, JG; Krenning, EP; Valkema, R; Verwijnen, SM | 1 |
| Bernard, BF; Breeman, WA; de Jong, M; de Visser, M; Erion, JL; Janssen, PJ; Krenning, EP; Srinivasan, A; Verwijnen, SM; Vulto, AG | 1 |
| Baidoo, K; Boswell, CA; Brechbiel, MW; Choyke, PL; Gunn, AJ; Milenic, DE; Xu, H | 1 |
| Abe, T; Ando, Y; Takahashi, T; Tanaka, H | 1 |
| Boerman, OC; Brom, M; Gotthardt, M; Joosten, L; Oyen, WJ | 1 |
| Berndsen, SC; Boerman, OC; de Jong, M; de Swart, J; de Visser, M; Koelewijn, S; Krenning, EP; Melis, M; Valkema, R | 1 |
| Chen, X; Li, M; Lin, J; Liu, H; Lv, S; Song, W; Tang, Z; Zhang, D | 1 |
1 trial(s) available for pentetic acid and lysine
| Article | Year |
|---|---|
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
Topics: Arginine; Carcinoma, Neuroendocrine; Female; Humans; Hyperkalemia; Infusions, Intravenous; Kidney; Lysine; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Vomiting | 2003 |
19 other study(ies) available for pentetic acid and lysine
| Article | Year |
|---|---|
Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.
Topics: Animals; Bacterial Proteins; Biotin; Edetic Acid; Escherichia coli Infections; Immunoglobulin G; Indium Radioisotopes; Lysine; Male; Mice; Pentetic Acid; Radioimmunodetection; Streptavidin; Tissue Distribution | 1992 |
Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Topics: Animals; Antioxidants; Arginine; Chelating Agents; Chromatography, High Pressure Liquid; Collagen; Cross-Linking Reagents; Electrophoresis, Polyacrylamide Gel; Female; Glucose; Glycosylation; Kinetics; Lysine; Maillard Reaction; Oxidation-Reduction; Pentetic Acid; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Tendons | 1994 |
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
Topics: Acetazolamide; Animals; Arginine; Cystine; Enzyme Inhibitors; Heptanoates; Kidney; Lysine; Male; Maleates; Octreotide; Pentetic Acid; Radionuclide Imaging; Rats; Rats, Wistar; Sensitivity and Specificity; Tissue Distribution | 1996 |
Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bacterial Proteins; Colonic Neoplasms; Female; Glycoproteins; Humans; Immunoconjugates; Indium Radioisotopes; Lysine; Mice; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Radionuclide Imaging; Streptavidin; Tissue Distribution; Transplantation, Heterologous | 1996 |
Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product.
Topics: Animals; Cell Line; Feces; Female; Glycoproteins; Kidney; Liver; Lysine; Mice; Pentetic Acid; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Topics: Animals; Indium Radioisotopes; Kidney; Lysine; Male; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Yttrium Radioisotopes | 1997 |
Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Chelating Agents; Copper; Edetic Acid; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Guanidines; Humans; Immunohistochemistry; Lipid Peroxidation; Lipoproteins, LDL; Lysine; Male; Malondialdehyde; Middle Aged; Pentetic Acid; Receptors, Immunologic; Receptors, Scavenger | 2001 |
Synthesis of N(alpha)-Boc-N(epsilon)-tetrabenzyl-DTPA-L-lysine and N(alpha)-Fmoc-N(epsilon)-tetra-t-butyl-DTPA-L-lysine, building blocks for solid phase synthesis of DTPA-containing peptides.
Topics: Acylation; Amino Acids; Chelating Agents; Fluorenes; Lysine; Pentetic Acid; Peptides | 2002 |
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lysine; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pentetic Acid; Peptides; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Rhenium; Technetium; Time Factors; Tissue Distribution | 2003 |
Identification of important residues in metal-chelate recognition by monoclonal antibodies.
Topics: Amino Acid Substitution; Amino Acids; Animals; Antibodies, Monoclonal; Antigens; Binding Sites, Antibody; Chelating Agents; Edetic Acid; Immunoassay; Immunoglobulin G; Lead; Lysine; Metals, Heavy; Mice; Mice, Inbred BALB C; Models, Molecular; Pentetic Acid; Protein Structure, Tertiary; Recombinant Proteins | 2003 |
Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging.
Topics: Animals; Antimony; Humans; Isothiocyanates; Lymph Nodes; Lysine; Male; Mannose; Mercaptoethanol; Mice; Models, Chemical; Pentetic Acid; Polymers; Protein Binding; Radiochemistry; Rats; Rats, Sprague-Dawley; Sentinel Lymph Node Biopsy; Technetium Compounds; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Medronate; Temperature; Thiocyanates; Time Factors; Tin Compounds; Tissue Distribution | 2004 |
Radioimmunotherapy of solid tumors by targeting extra domain B fibronectin: identification of the best-suited radioimmunoconjugate.
Topics: Animals; Bone Marrow; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dimerization; Electrophoresis, Polyacrylamide Gel; Fibronectins; Humans; Immunoconjugates; Immunoglobulin Fragments; Immunoglobulin G; Lysine; Mice; Neoplasms; Pentetic Acid; Protein Structure, Tertiary; Radioimmunotherapy; Radiometry; Time Factors | 2005 |
Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide.
Topics: Administration, Oral; Animals; Arginine; Autoradiography; Eosine Yellowish-(YS); Hematoxylin; Indium Radioisotopes; Infusions, Intravenous; Kidney; Lysine; Male; Models, Statistical; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Time Factors; Tissue Distribution | 2005 |
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.
Topics: Analysis of Variance; Animals; Colonic Neoplasms; Humans; Indium Radioisotopes; Kidney; Lysine; Male; Mice; Mice, Nude; Neurotensin; Oligopeptides; Pentetic Acid; Radiography; Tissue Distribution; Transplantation, Heterologous | 2007 |
Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Binding, Competitive; Carbocyanines; Cell Line, Tumor; Chelating Agents; Drug Design; Flow Cytometry; Fluorescent Dyes; Humans; Immunoconjugates; Indium Radioisotopes; Isothiocyanates; Lysine; Pentetic Acid; Positron-Emission Tomography; Radioimmunoassay; Radiopharmaceuticals; Trastuzumab; Yttrium Radioisotopes | 2007 |
The synthesis of D-trihydroxyllysine-based oligopeptides as a hydrophilic scaffold and its application to the synthesis of bifunctional chelating agents for use as bone tracers.
Topics: Animals; Bone and Bones; Chelating Agents; Cross-Linking Reagents; Diphosphonates; Durapatite; Injections, Intravenous; Lysine; Male; Oligopeptides; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Tissue Distribution | 2008 |
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
Topics: Amino Acid Sequence; Animals; Biological Transport; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Injections; Insulinoma; Kinetics; Lysine; Mice; Molecular Sequence Data; Pentetic Acid; Peptides; Positron-Emission Tomography; Rats | 2010 |
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.
Topics: Albumins; Animals; Autoradiography; Creatinine; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Tubules; Lysine; Male; Octreotide; Organometallic Compounds; Pentetic Acid; Proteinuria; Radiation Injuries; Radioisotope Renography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Mertiatide; Tomography, Emission-Computed, Single-Photon | 2010 |
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Lysine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Oxidation-Reduction; Paclitaxel; Pentetic Acid; Polyethylene Glycols; Polymers | 2014 |